Skip to main content

Want a detailed portfolio tracker?

Cel-Sci (CVM) P/E (2010 - 2026)

Cel-Sci (CVM) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Cel-Sci (CVM) P/E is -0.26. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cel-Sci (CVM)

YearP/EChange
2026-0.26-75.86%
2025-1.09+23.51%
2024-0.88-76.51%
2023-3.77+35.80%
2022-2.77-65.71%
2021-8.09-40.19%
2020-13.52+0.39%
2019-13.47+406.43%
2018-2.66-63.09%
2017-7.21+12.49%
2016-6.41-81.84%
2015-35.27+18.15%
2014-29.85+50.90%
2013-19.78-61.09%
2012-50.84+118.67%
2011-23.25-90.08%
2010-234.33N/A

Comparison Cel-Sci (CVM) P/E with competitors

Cel-Sci (CVM) P/E is -0.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.64%
NBYStablecoin Development Corp0.00-101.63%
ENLVEnlivex Ltd0.07-128.35%
FGENFibroGen Inc0.24-190.97%
CHRSCoherus Biosciences Inc0.85-421.59%
FBIOFortress Biotech Inc0.95-459.68%
ORMPOramed Pharmaceuticals Inc1.50-669.64%
AGENAgenus Inc3.01-1240.61%
INVAInnoviva Inc3.15-1295.34%
VXRTVaxart Inc3.55-1445.32%
CRMDCorMedix Inc3.63-1475.14%
CVACCureVac N.V.4.45-1784.87%
GLPGGalapagos NV4.86-1941.47%
SRPTSarepta Therapeutics Inc4.88-1950.26%
ABEOAbeona Therapeutics Inc5.39-2141.81%
ABUSArbutus Biopharma Corp5.60-2220.68%
ZVRAZevra Therapeutics Inc5.89-2331.20%
SPROSpero Therapeutics Inc6.23-2460.52%
CGENCompugen Ltd6.31-2492.92%
RIGLRigel Pharmaceuticals6.87-2704.44%
SLXNSilexion Therapeutics Corp7.30-2865.14%
OMEROmeros Corporation9.26-3608.98%
AUPHAurinia Pharmaceuticals Inc9.58-3732.61%
PLXProtalix BioTherapeutics Inc10.89-4227.59%
ACADAcadia Pharmaceuticals Inc11.73-4545.01%
TBPHTheravance Biopharma Inc12.26-4747.24%
ADMAAdma Biologics Inc12.42-4806.37%
HRMYHarmony Biosciences Holdings Inc13.82-5337.73%
SABSSAB Biotherapeutics Inc14.14-5457.50%
NAGENiagen Bioscience Inc14.82-5715.94%
INCYIncyte Corp15.82-6096.61%
REGNRegeneron Pharmaceuticals Inc15.86-6109.54%
PBYIPuma Biotechnology Inc17.32-6662.50%
CPRXCatalyst Pharmaceuticals Inc17.44-6709.35%
EXELExelixis Inc17.54-6746.76%
TGTXTG Therapeutics Inc18.97-7287.98%
MDXGMimedx Group Inc20.55-7889.23%
XOMAXOMA Royalty Corp22.87-8769.54%
ARGXArgen X SE24.30-9308.98%
CTMXCytomX Therapeutics Inc24.82-9507.24%
XOMAOXOMA Royalty Corp25.34-9705.72%
HALOHalozyme Therapeutics Inc25.62-9811.43%
XOMAPXOMA Royalty Corp25.67-9829.01%
VRTXVertex Pharmaceuticals Inc27.99-10710.05%
RPRXRoyalty Pharma plc - Class A28.69-10972.62%
SLNOSoleno Therapeutics Inc29.02-11096.86%
ASNDAscendis Pharma A/S30.09-11502.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-14468.71%
APLSApellis Pharmaceuticals Inc39.02-14889.11%
BMRNBiomarin Pharmaceutical Inc42.21-16098.36%
KRYSKrystal Biotech Inc45.34-17285.25%
ONCBeiGene Ltd69.54-26455.95%
PHARPharming Group N.V.75.03-28534.83%
TECHBio-Techne Corp101.96-38742.41%
VCELVericel Corp109.92-41760.39%
ALNYAlnylam Pharmaceuticals Inc117.96-44808.99%
GMABGenmab140.29-53270.46%
TLXTelix Pharmaceuticals Ltd162.15-61556.22%
CORTCorcept Therapeutics Inc212.86-80773.39%